Posted by Michael Wonder on 29 Sep 2019
Advocates frustrated after PHARMAC stops funding two epilepsy drugs
29 September 2019 - From Tuesday, PHARMAC will stop funding two drugs affecting thousands of people with epilepsy.
The decision to switch everyone onto the same drug has advocates frustrated and disappointed.
One four-year-old girl, Mathilda, was diagnosed with the condition that affects one in 100 New Zealanders a year ago.
